Language selection

Search

2005-10-25 - Male - 6 Years old

192513

Adverse reaction report number 192513
Latest AER version number 0
Market authorization holder AER number SUS1200500787
Initial received date 2005-10-25
Latest received date 2005-10-25
Age 6 Years
Gender Male
Weight N/A
Type of report Spontaneous
Reporter type Pharmacist
Source of report MAH
Report outcome Unknown
Serious report? Yes

Reason for seriousness

Death
Disability
Cogenital anomaly
Life threateting
Hospitalization
Other medically important Yes

Product information

Product description Dosage form Health product role Route of administration Dose Frequency Therapy duration Indication(s)
ADDERALL XRCAPSULE, EXTENDED RELEASESuspectOral25 Milligram1 every 1 Day(s)

Adverse reaction term information

MedDRA version: v.21.1
Adverse reaction terms Reaction duration
Agitation
Hallucination
Insomnia
Date modified: